“Since its approval, Talzenna in combination with Xtandi has redefined the standard of care for those living with homologous recombination repair gene-mutated mCRPC. These latest data from TALAPRO-2 ...
Recent actions by the FDA and NIH in response to the current political climate have left key stakeholders in clinical trials ...
Sepehr Shojaei, VP of Design Solutions at Lightship, talks about how the company works with pharma and contract research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results